← SynDRA
RO-201724
SynDRA canonical compound SYN0001065 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
| Primary target(s) | PDE4D |
| Mechanism of action | Phosphodiesterase inhibitor |
All known targets
- PDE4A
- PDE4B
- PDE4D
- PDE4C
- CDC25A
- PDE3A
Mechanisms of action (all sources)
- Phosphodiesterase inhibitor
- PDE4A INHIBITOR
- PDE4B INHIBITOR
- PDE4C INHIBITOR
- PDE4D INHIBITOR
- CDC25A INHIBITOR
Drug classes
- Phosphodiesterase Inhibitors
Cross-references
Synonyms
- ro-20-1724
- 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone
- 4-(3-Butoxy-4-methoxybenzyl)imidazolidin-2-one
- CHEMBL18701
- 4-[(3-butoxy-4-methoxyphenyl)methyl]imidazolidin-2-one
- 2-Imidazolidinone, 4-((3-butoxy-4-methoxyphenyl)methyl)-
- 2-Imidazolidinone, 4-((3-butoxy-4-methoxyphenyl)methyl)-, (+-)-
- 4-(3-butoxy-4-methoxy-benzyl)imidazolidin-2-one
- 4-(3-butoxy-4-methoxyphenyl)methyl-2-imidazolidone
- SR-01000075647
- keratan sulfate I
- Keratan sulphate I
- Naphthoquinone analogs
- Ro-20-1724
- DIW6F13QW2
- 4-[(3-butoxy-4-methoxyphenyl)methyl]-2-imidazolidinone
- 4-((3-Butoxy-4-methoxyphenyl)methyl)-2-imidazolidinone
- Ro 1724
- RefChem:509185
- DTXCID001380469
- Ro20-1724
- 4- (3-BUTOXY-4-METHOXYBENZYL)IMIDAZOLIDIN-2-ONE
- R 020-1724
- Ro 20-1724; Ro 20-174; Roche 20-1724
- UNII-DIW6F13QW2
- Spectrum_001840
- Keratan sulfuric acid I
- Keratan sulphuric acid I
- Spectrum3_001826
- Lopac0_000204
- BSPBio_001358
- BSPBio_002560
- BSPBio_003471
- KBioGR_000078
- KBioSS_000078
- KBioSS_002345
- MLS000859915
- SPECTRUM2300287
- GTPL5258
Look up RO-201724 in the interactive SynDRA portal →